Serotonin releasing agents: Neurochemical, therapeutic and adverse effects
Open Access
- 30 April 2002
- journal article
- review article
- Published by Elsevier in Pharmacology Biochemistry and Behavior
- Vol. 71 (4) , 825-836
- https://doi.org/10.1016/s0091-3057(01)00669-4
Abstract
No abstract availableKeywords
This publication has 93 references indexed in Scilit:
- Effect of Fenfluramine Challenge on Cocaine Craving in Addicted Male UsersThe American Journal on Addictions, 1998
- Valvular Heart Disease Associated with Fenfluramine–PhentermineNew England Journal of Medicine, 1997
- Single and multiple dose pharmacokinetics of nefazodone in subjects classified as extensive and poor metabolizers of dextromethorphanBritish Journal of Clinical Pharmacology, 1996
- The Addition of Dexfenfluramine to Fluoxetine in the Treatment of Obesity: A Randomized Clinical TrialObesity Research, 1996
- Appetite-Suppressant Drugs and the Risk of Primary Pulmonary HypertensionNew England Journal of Medicine, 1996
- Multiple Serotonin Receptors: Opportunities for New Treatments for Obesity?Obesity Research, 1995
- Biological Actions of Drugs Affecting Serotonin and EatingObesity Research, 1995
- Effects of chronic treatment with dexfenfluramine on serotonin in rat blood, brain and lung tissueLife Sciences, 1994
- Neurotransmitter Transporters: Recent ProgressAnnual Review of Neuroscience, 1993
- Fenfluramine Augmentation in Tricyclic-RefractoryJournal of Clinical Psychopharmacology, 1990